Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study

BACKGROUND: A new descriptive classification scheme for biomarkers used in Alzheimer's and cognitive aging research, labeled ATN, was recently proposed. One implementation of this ATN construct dichotomizes biomarkers of amyloid, tau, and neurodegeneration/neuronal injury as normal or abnormal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Neurol
Autori principali: Jack, Clifford R., Wiste, Heather J., Weigand, Stephen D., Therneau, Terry M., Knopman, David S., Lowe, Val, Vemuri, Prashanthi, Mielke, Michelle M., Roberts, Rosebud O., Machulda, Mary M., Senjem, Matthew L., Gunter, Jeffrey L., Rocca, Walter A., Petersen, Ronald C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5516534/
https://ncbi.nlm.nih.gov/pubmed/28456479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(17)30077-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi